340 related articles for article (PubMed ID: 7918471)
21. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
[TBL] [Abstract][Full Text] [Related]
22. A method for detection of 4-hydroxy-2-nonenal adducts in proteins.
Wakita C; Honda K; Shibata T; Akagawa M; Uchida K
Free Radic Biol Med; 2011 Jul; 51(1):1-4. PubMed ID: 21457776
[TBL] [Abstract][Full Text] [Related]
23. Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.
Viita H; Närvänen O; Ylä-Herttuala S
Life Sci; 1999; 65(8):783-93. PubMed ID: 10466744
[TBL] [Abstract][Full Text] [Related]
24. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues.
Crabb JW; O'Neil J; Miyagi M; West K; Hoff HF
Protein Sci; 2002 Apr; 11(4):831-40. PubMed ID: 11910026
[TBL] [Abstract][Full Text] [Related]
25. Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde.
Hoff HF; O'Neil J
J Lipid Res; 1993 Jul; 34(7):1209-17. PubMed ID: 8371068
[TBL] [Abstract][Full Text] [Related]
26. HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques.
Salomon RG; Kaur K; Podrez E; Hoff HF; Krushinsky AV; Sayre LM
Chem Res Toxicol; 2000 Jul; 13(7):557-64. PubMed ID: 10898587
[TBL] [Abstract][Full Text] [Related]
27. Investigating the role of H₂S in 4-HNE scavenging.
Laggner H; Gmeiner BM
Methods Enzymol; 2015; 555():3-18. PubMed ID: 25747472
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
[TBL] [Abstract][Full Text] [Related]
29. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.
Knott HM; Brown BE; Davies MJ; Dean RT
Eur J Biochem; 2003 Sep; 270(17):3572-82. PubMed ID: 12919321
[TBL] [Abstract][Full Text] [Related]
30. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
31. Involvement of aldose reductase in the metabolism of atherogenic aldehydes.
Srivastava S; Liu SQ; Conklin DJ; Zacarias A; Srivastava SK; Bhatnagar A
Chem Biol Interact; 2001 Jan; 130-132(1-3):563-71. PubMed ID: 11306075
[TBL] [Abstract][Full Text] [Related]
32. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction.
Uchida K; Stadtman ER
J Biol Chem; 1993 Mar; 268(9):6388-93. PubMed ID: 8454610
[TBL] [Abstract][Full Text] [Related]
33. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions.
Mendez D; Hernaez ML; Diez A; Puyet A; Bautista JM
J Proteome Res; 2010 Nov; 9(11):5770-81. PubMed ID: 20818828
[TBL] [Abstract][Full Text] [Related]
34. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
35. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).
Jürgens G; Chen Q; Esterbauer H; Mair S; Ledinski G; Dinges HP
Arterioscler Thromb; 1993 Nov; 13(11):1689-99. PubMed ID: 7692957
[TBL] [Abstract][Full Text] [Related]
36. Computational and physicochemical insight into 4-hydroxy-2-nonenal induced structural and functional perturbations in human low-density lipoprotein.
Tufail N; Abidi M; Warsi MS; Kausar T; Nayeem SM;
J Biomol Struct Dyn; 2024 Mar; 42(5):2698-2713. PubMed ID: 37154523
[TBL] [Abstract][Full Text] [Related]
37. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.
Scaccini C; Chiesa G; Jialal I
J Lipid Res; 1994 Jun; 35(6):1085-92. PubMed ID: 8077847
[TBL] [Abstract][Full Text] [Related]
38. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies.
Weber D; Milkovic L; Bennett SJ; Griffiths HR; Zarkovic N; Grune T
Redox Biol; 2013; 1(1):226-33. PubMed ID: 24024156
[TBL] [Abstract][Full Text] [Related]
39. Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids.
Yamada S; Funada T; Shibata N; Kobayashi M; Kawai Y; Tatsuda E; Furuhata A; Uchida K
J Lipid Res; 2004 Apr; 45(4):626-34. PubMed ID: 14729859
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL.
Kato Y; Tokunaga K; Osawa T
Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
